ES2071610T3 - Proteina l y sus subfragmentos, con actividad de union a inmunoglobulinas, un procedimiento para su preparacion, estuche de reactivos, composicion farmaceutica y una cepa de peptococcus magnus. - Google Patents

Proteina l y sus subfragmentos, con actividad de union a inmunoglobulinas, un procedimiento para su preparacion, estuche de reactivos, composicion farmaceutica y una cepa de peptococcus magnus.

Info

Publication number
ES2071610T3
ES2071610T3 ES87850048T ES87850048T ES2071610T3 ES 2071610 T3 ES2071610 T3 ES 2071610T3 ES 87850048 T ES87850048 T ES 87850048T ES 87850048 T ES87850048 T ES 87850048T ES 2071610 T3 ES2071610 T3 ES 2071610T3
Authority
ES
Spain
Prior art keywords
subfragments
protein
immunoglobulins
pharmaceutical composition
union
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87850048T
Other languages
English (en)
Inventor
Lars Bjorck
Mats Erntell
Erling B Myhre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hightech Receptor AB
Original Assignee
Hightech Receptor AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hightech Receptor AB filed Critical Hightech Receptor AB
Application granted granted Critical
Publication of ES2071610T3 publication Critical patent/ES2071610T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/803—Physical recovery methods, e.g. chromatography, grinding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIERE A UNA NUEVA PROTEINA L Y SUBFRAGMENTOS DE LA MISMA CON ACTIVIDAD LIGANTE PARA TODA CLASE DE INMUNOGLOBULINAS DE DIFERENTES ESPECIES, UN PROCEDIMIENTO PARA OBTENERLA, UN CONJUNTO DE REACTIVOS Y UNA COMPOSICION FARMACOLOGICA. EL PROCEDIMINETO PARA OBTENER LA PROTEINA Y LOS SUBFRAGMENTOS DE LA MISMA SE CARACTERIZA PORQUE EL MICROORGANISMO PEPTOCOCUS MAGNUM 312 SE TRATA CON ENZIMAS PROTEOLITICAS O MUTANOLISINA.
ES87850048T 1986-07-22 1987-02-11 Proteina l y sus subfragmentos, con actividad de union a inmunoglobulinas, un procedimiento para su preparacion, estuche de reactivos, composicion farmaceutica y una cepa de peptococcus magnus. Expired - Lifetime ES2071610T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/887,926 US4876194A (en) 1986-07-22 1986-07-22 Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain

Publications (1)

Publication Number Publication Date
ES2071610T3 true ES2071610T3 (es) 1995-07-01

Family

ID=25392158

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87850048T Expired - Lifetime ES2071610T3 (es) 1986-07-22 1987-02-11 Proteina l y sus subfragmentos, con actividad de union a inmunoglobulinas, un procedimiento para su preparacion, estuche de reactivos, composicion farmaceutica y una cepa de peptococcus magnus.

Country Status (6)

Country Link
US (1) US4876194A (es)
EP (1) EP0255497B1 (es)
JP (1) JP2528302B2 (es)
AT (1) ATE121419T1 (es)
DE (1) DE3751249T2 (es)
ES (1) ES2071610T3 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5245016A (en) * 1991-01-31 1993-09-14 University Of Utah Research Foundation Pseudomonas maltophilia immunoglobulin binding protein and methods for its use
JPH06506114A (ja) * 1991-03-29 1994-07-14 ファウルマン，　エルビン 新規な遺伝子及びＩｇＡ結合蛋白質の製造方法
SE9201331D0 (sv) * 1992-04-28 1992-04-28 Hightech Receptor C O Active Protein l och hybridproteiner daerav
AU672794B2 (en) * 1992-05-07 1996-10-17 Affitech As Immunoglobulin binding proteins derived from L protein and their uses
GB9209804D0 (en) * 1992-05-07 1992-06-24 Health Lab Service Board Novel immunoglobulin binding proteins process for their production and recombinant dna molecules coding therefor
EP1042459A4 (en) * 1997-12-24 2003-07-23 Diatech Pty Ltd BIFUNCTIONAL MOLECULES
GB9929937D0 (en) * 1999-12-17 2000-02-09 Actinova Ltd Antigen delivery
WO2004076634A2 (en) * 2003-02-24 2004-09-10 Ira Sanders Cell membrane translocation of regulated snare inhibitors , compositions therefor, and methods for treatment of disease
CN102046809A (zh) * 2008-04-05 2011-05-04 单细胞科技公司 筛选产生生物活性剂的单细胞的方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2487198A1 (fr) * 1980-07-28 1982-01-29 Berri Balzac Sa Nouvelle substance immuno-suppressive, son procede d'isolement et son application en therapeutique
US5151350A (en) * 1982-10-27 1992-09-29 Repligen Corporation Cloned genes encoding recombinant protein a
FR2550707B1 (fr) * 1983-08-17 1986-02-28 Lipha Medicament immunomodulateur d'origine biologique et son procede de preparation

Also Published As

Publication number Publication date
DE3751249D1 (de) 1995-05-24
JP2528302B2 (ja) 1996-08-28
US4876194A (en) 1989-10-24
DE3751249T2 (de) 1995-08-31
EP0255497A3 (en) 1989-03-22
JPS6332372A (ja) 1988-02-12
EP0255497A2 (en) 1988-02-03
EP0255497B1 (en) 1995-04-19
ATE121419T1 (de) 1995-05-15

Similar Documents

Publication Publication Date Title
DE3586159D1 (de) Zusammensetzung und verfahren zur differenzierung von weissen blutzellen.
DE3382694D1 (de) Expression, bearbeitung und ausscheidung von heterologem protein durch hefen.
DE3789881D1 (de) Verfahren zur Herstellung von Photomasken und Photomaske.
DE3587549D1 (de) Ergänzungstestverfahren von proteine bindenden enzymen.
DE3765446D1 (de) Uebertragungsmaterial von musterungen.
DE3750789D1 (de) Datenverarbeitungssystem und -verfahren zur direkten und indirekten Ausführung von gleichmässig strukturierten Objekttypen.
DE3881315T2 (de) Nassentschwefelungsverfahren zur Behandlung von Abgasen.
SE8801701D0 (sv) Production technology based on enzymic method
ES2071610T3 (es) Proteina l y sus subfragmentos, con actividad de union a inmunoglobulinas, un procedimiento para su preparacion, estuche de reactivos, composicion farmaceutica y una cepa de peptococcus magnus.
DE3781528D1 (de) Verfahren zur oktanzahlsteigerung und zur verringerung des schwefelgehaltes von olefinischen benzinen.
DE3680546D1 (de) Prozess zur reduktion von aldehyden und ketonen.
ES2019384B3 (es) Mejora de un contactor biologico rotatorio y un metodo para su fabricacion.
ATE56990T1 (de) Verfahren und reagenz zur bestimmung von gesamt- bilirubin.
DE59008012D1 (de) Mittel zur Behandlung von Leder und Pelzen.
DE3761088D1 (de) Verbessertes verfahren zur herstellung von p-cymol und homologen alkylbenzolen.
DE3886450T2 (de) Aus Nukleinsäuren von menschlichen Papillomaviren bestehende Hybridisierungsproben und Methoden für deren Anwendung.
DE3669737D1 (de) Zubereitungen und verfahren zum zurichten von leder und zur textilbeschichtung.
ATE61350T1 (de) Verfahren zur fabrikation von n-(sulfonylmethyl)- formamiden und von sulfonylmethylisocyaniden.
DE3784891T2 (de) Verfahren zur Isolierung von säurestabilen, biologisch aktiven Proteinen.
IL83077A0 (en) Process and reagent for the determination of creatinine and an enzyme suitable for this
DE69002838D1 (de) Verfahren zur Verbesserung für die Naturtrocknung von biologischen Produkten und dadurch behandelte Produkte.
ATE75261T1 (de) Testreagens zur bestimmung von amylase.
ATE48016T1 (de) Methoden zur reinigung und reaktivierung von gefaellten heterologen proteinen.
DE3873255D1 (de) Methoden und praeparate zur vorbeugung von ulcera.
ATE33150T1 (de) Verfahren und reagenz zur vollenzymatischen bestimmung von harnstoff.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 255497

Country of ref document: ES